ENTRY       D10512            Mixture   Drug
NAME        Brinzolamide and timolol maleate;
            Azorga (TN)
COMPONENT   Brinzolamide [DR:D00652], Timolol maleate [DR:D00603]
CLASS       Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
              DG03030  Combination of carbonic anhydrase inhibitor and beta blocker
            Metabolizing enzyme substrate
             DG01638  CYP2A6 substrate
             DG02919  CYP2B6 substrate
             DG02918  CYP2C8 substrate
             DG01642  CYP2C9 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1319
            ATC code: S01EC54 S01ED51
            Product: D10512<JP>
EFFICACY    Antiglaucoma
COMMENT     Carbonic anhydrase inhibitor / bete-adrenergic receptor antagonist combination
            Brinzolamide is metabolized by CYP3A4 with some contribution from CYP2A6, CYP2B6, CYP2C8 and CYP2C9.
            Timolol is primarily metabolized by CYP2D6.
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]; CYP2A6 [HSA:1548], CYP2B6 [HSA:1555], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EC Carbonic anhydrase inhibitors
                 S01EC54 Brinzolamide, combinations
                  D10512  Brinzolamide and timolol maleate &lt;JP&gt;
                S01ED Beta blocking agents
                 S01ED51 Timolol, combinations
                  D10512  Brinzolamide and timolol maleate &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D10512  Brinzolamide and timolol maleate
            Drug groups [BR:br08330]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG03030  Combination of carbonic anhydrase inhibitor and beta blocker
                D10512  Brinzolamide and timolol maleate
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               D10512  Brinzolamide and timolol maleate
              DG02919  CYP2B6 substrate
               D10512  Brinzolamide and timolol maleate
              DG02918  CYP2C8 substrate
               D10512  Brinzolamide and timolol maleate
              DG01642  CYP2C9 substrate
               D10512  Brinzolamide and timolol maleate
              DG01644  CYP2D6 substrate
               D10512  Brinzolamide and timolol maleate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10512  Brinzolamide and timolol maleate
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D10512  Brinzolamide and timolol maleate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10512
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10512
DBLINKS     PubChem: 172232605
///
